The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
29
No.
9
September 29, 2006Sep 29, 2006
Free
DOWNLOAD THE PDF

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

Long-Term Remissions Shown With Chemo Plus Radiation

Raloxifene Protects Women At High or Low Risk of Disease

Study Needs 23,000 Women Whose Sisters Have Cancer

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

Breast Density As Important As Age In Determining Risk

Ovariectomy Without HRT Increases Death Rate

NCI-Approved Clinical Trials

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account